Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 5,617 shares at $8.56 ($48K) on 2022-03-02, disclosed to the SEC on 2022-03-03.
Scheduled sale ($48k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2024-05-17 | $122K | — | Filing → |
| DYN | SELL | 2024-03-12 | $67K | — | Filing → |
| DYN | SELL | 2024-03-11 | $472K | — | Filing → |